Ureter Cancer Clinical Trials
3 recruiting trials for Ureter Cancer. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Ureter Cancer clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Peking University First Hospital (1), Yonsei University (1), University of Nebraska (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Systematic therapy combined with radiotherapy (radiation, 1 trial), followed by Systematic drug treatment.
Track Ureter Cancer trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs
This study was a prospective, open-label, phase II randomised controlled clinical study, enrolling patients with primary oligometastatic uroepithelial carcinoma, oligometastasis...
Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing...
Genitourinary malignancies such as prostate cancer, renal cell cancer, and bladder cancer in Korean population have been increased due to the aged population and the westernized...
Integrated Cancer Repository for Cancer Research
The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Ureter Cancer, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Ureter Cancer, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Ureter Cancer, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.